← Open Payments lookup

AKEELA BENSON: Open Payments

NPI 1679998827 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,780 in 80 payments from 11 companies in 2025. Trend: 2023 $1,078 · 2024 $1,070 · 2025 $5,780

Food & beverage: $3,721Travel & lodging: $2,060
CompanyPaymentsAmount
Janssen Research & Development, LLC13$1,554
Neurocrine BioSciences, Inc.18$1,468
Alkermes, Inc.12$615
Otsuka America Pharmaceutical, Inc.3$360
Janssen Pharmaceuticals, Inc8$336
Teva Pharmaceuticals USA, Inc.8$309
ABBVIE INC.6$307
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$293
E.R. Squibb & Sons, L.L.C.1$271
Indivior Inc.6$142

Products named: ARISTADA, INVEGA SUSTENNA, VRAYLAR, CAPLYTA, UZEDY, LYBALVI, ABILIFY MAINTENA, INGREZZA.

Industry payments across CA — which companies pay providers there.